Systematic Review and Meta-Analysis on the Association between IL-1B Polymorphisms and Cancer Risk

PLoS ONE

Volumn 8, Issue 5, 2013, Pages

  Xu, Jiali ^a   Yin, Zhiqiang ^a   Cao, Songyu ^b   Gao, Wen ^a   Liu, Lingxiang ^a   Yin, Yongmei ^a   Liu, Ping ^a   Shu, Yongqian ^a  

^a THE FIRST AFFILIATED HOSPITAL OF NANJING MEDICAL UNIVERSITY   (China)

^b NANJING MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOSINE; INTERLEUKIN 1BETA; THYMINE;

ARTICLE; CANCER RISK; CANCER SUSCEPTIBILITY; GENETIC ASSOCIATION; GENETIC HETEROGENEITY; HOSPITAL BASED CASE CONTROL STUDY; HUMAN; LIVER CELL CARCINOMA; META ANALYSIS (TOPIC); SINGLE NUCLEOTIDE POLYMORPHISM; STOMACH CARCINOMA; SYSTEMATIC REVIEW; UTERINE CERVIX CANCER;

GENETIC ASSOCIATION STUDIES; GENETIC PREDISPOSITION TO DISEASE; HUMANS; INTERLEUKIN-1BETA; MODELS, GENETIC; NEOPLASMS; POLYMORPHISM, SINGLE NUCLEOTIDE; PUBLICATION BIAS; REGRESSION ANALYSIS; RISK FACTORS;

EID: 84877977924     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0063654     Document Type: Article

References (126)

1. Pharoah PD, Dunning AM, Ponder BA, Easton DF, (2004) Association studies for finding cancer-susceptibility genetic variants. Nat Rev Cancer 4: 850-860.
2. Coussens LM, Werb Z, (2002) Inflammation and cancer. Nature 420: 860-867.
3. Schottenfeld D, Beebe-Dimmer J, (2006) Chronic inflammation: a common and important factor in the pathogenesis of neoplasia. CA Cancer J Clin 56: 69-83.
4. Colotta F, Allavena P, Sica A, Garlanda C, Mantovani A, (2009) Cancer-related inflammation, the seventh hallmark of cancer: links to genetic instability. Carcinogenesis 30: 1073-1081.
5. Germano G, Allavena P, Mantovani A, (2008) Cytokines as a key component of cancer-related inflammation. Cytokine 43: 374-379.
6. Mantovani A, (2010) Molecular pathways linking inflammation and cancer. Curr Mol Med 10: 369-373.
7. Mantovani A, Savino B, Locati M, Zammataro L, Allavena P, et al. (2010) The chemokine system in cancer biology and therapy. Cytokine Growth Factor Rev 21: 27-39.
8. Smyth MJ, Cretney E, Kershaw MH, Hayakawa Y, (2004) Cytokines in cancer immunity and immunotherapy. Immunol Rev 202: 275-293.
9. Seruga B, Zhang H, Bernstein LJ, Tannock IF, (2008) Cytokines and their relationship to the symptoms and outcome of cancer. Nat Rev Cancer 8: 887-899.
10. Jin P, Panelli MC, Marincola FM, Wang E, (2004) Cytokine polymorphism and its possible impact on cancer. Immunol Res 30: 181-190.
11. Kurzrock R, (2001) Cytokine deregulation in cancer. Biomed Pharmacother 55: 543-547.
12. Grivennikov SI, Greten FR, Karin M, (2010) Immunity, inflammation, and cancer. Cell 140: 883-899.
13. Dinarello CA, (1996) Biologic basis for interleukin-1 in disease. Blood 87: 2095-2147.
14. Bird S, Zou J, Wang T, Munday B, Cunningham C, et al. (2002) Evolution of interleukin-1beta. Cytokine Growth Factor Rev 13: 483-502.
15. Apte RN, Voronov E, (2008) Is interleukin-1 a good or bad 'guy' in tumor immunobiology and immunotherapy? Immunol Rev 222: 222-241.
16. Saijo Y, Tanaka M, Miki M, Usui K, Suzuki T, et al. (2002) Proinflammatory cytokine IL-1 beta promotes tumor growth of Lewis lung carcinoma by induction of angiogenic factors: in vivo analysis of tumor-stromal interaction. J Immunol 169: 469-475.
17. Song X, Voronov E, Dvorkin T, Fima E, Cagnano E, et al. (2003) Differential effects of IL-1 alpha and IL-1 beta on tumorigenicity patterns and invasiveness. J Immunol 171: 6448-6456.
18. Voronov E, Shouval DS, Krelin Y, Cagnano E, Benharroch D, et al. (2003) IL-1 is required for tumor invasiveness and angiogenesis. Proc Natl Acad Sci U S A 100: 2645-2650.
19. El-Omar EM, Carrington M, Chow WH, McColl KE, Bream JH, et al. (2000) Interleukin-1 polymorphisms associated with increased risk of gastric cancer. Nature 404: 398-402.
20. Machado JC, Pharoah P, Sousa S, Carvalho R, Oliveira C, et al. (2001) Interleukin 1B and interleukin 1RN polymorphisms are associated with increased risk of gastric carcinoma. Gastroenterology 121: 823-829.
21. Chen H, Wilkins LM, Aziz N, Cannings C, Wyllie DH, et al. (2006) Single nucleotide polymorphisms in the human interleukin-1B gene affect transcription according to haplotype context. Hum Mol Genet 15: 519-529.
22. Lind H, Haugen A, Zienolddiny S, (2007) Differential binding of proteins to the IL1B-31 T/C polymorphism in lung epithelial cells. Cytokine 38: 43-48.
23. Hall SK, Perregaux DG, Gabel CA, Woodworth T, Durham LK, et al. (2004) Correlation of polymorphic variation in the promoter region of the interleukin-1 beta gene with secretion of interleukin-1 beta protein. Arthritis Rheum 50: 1976-1983.
24. Pociot F, Molvig J, Wogensen L, Worsaae H, Nerup J, (1992) A TaqI polymorphism in the human interleukin-1 beta (IL-1 beta) gene correlates with IL-1 beta secretion in vitro. Eur J Clin Invest 22: 396-402.
25. Hernandez-Guerrero C, Monzon-Bordonaba F, Jimenez-Zamudio L, Ahued-Ahued R, Arechavaleta-Velasco F, et al. (2003) In-vitro secretion of proinflammatory cytokines by human amniochorion carrying hyper-responsive gene polymorphisms of tumour necrosis factor-alpha and interleukin-1beta. Mol Hum Reprod 9: 625-629.
26. He B, Zhang Y, Pan Y, Xu Y, Gu L, et al. (2011) Interleukin 1 beta (IL1B) promoter polymorphism and cancer risk: evidence from 47 published studies. Mutagenesis 26: 637-642.
27. Wells GA, Shea B, O'Connell D, Petersen J, Welch V (Accessed 2012 Sep 30.) The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomized studies in meta-analyses. Available: http://wwwohrica/programs/clinical_epidemiology/oxfordhtm.
28. Handoll HH, (2006) Systematic reviews on rehabilitation interventions. Arch Phys Med Rehabil 87: 875.
29. Higgins JP, Thompson SG, (2002) Quantifying heterogeneity in a meta-analysis. Stat Med 21: 1539-1558.
30. Peters JL, Sutton AJ, Jones DR, Abrams KR, Rushton L, (2006) Comparison of two methods to detect publication bias in meta-analysis. Jama 295: 676-680.
31. Machado JC, Figueiredo C, Canedo P, Pharoah P, Carvalho R, et al. (2003) A proinflammatory genetic profile increases the risk for chronic atrophic gastritis and gastric carcinoma. Gastroenterology 125: 364-371.
32. Gatti LL, Burbano RR, de Assumpcao PP, Smith Mde A, Payao SL, (2004) Interleukin-1beta polymorphisms, Helicobacter pylori infection in individuals from Northern Brazil with gastric adenocarcinoma. Clin Exp Med 4: 93-98.
33. zur Hausen A, Crusius JB, Murillo LS, Alizadeh BZ, Morre SA, et al. (2003) IL-1B promoter polymorphism and Epstein-Barr virus in Dutch patients with gastric carcinoma. Int J Cancer 107: 866-867.
34. Persson C, Engstrand L, Nyren O, Hansson LE, Enroth H, et al. (2009) Interleukin 1-beta gene polymorphisms and risk of gastric cancer in Sweden. Scand J Gastroenterol 44: 339-345.
35. Ito H, Kaneko K, Makino R, Konishi K, Kurahashi T, et al. (2007) Interleukin-1beta gene in esophageal, gastric and colorectal carcinomas. Oncol Rep 18: 473-481.
36. Zabaleta J, Lin HY, Sierra RA, Hall MC, Clark PE, et al. (2008) Interactions of cytokine gene polymorphisms in prostate cancer risk. Carcinogenesis 29: 573-578.
37. Wu MS, Chen LT, Shun CT, Huang SP, Chiu HM, et al. (2004) Promoter polymorphisms of tumor necrosis factor-alpha are associated with risk of gastric mucosa-associated lymphoid tissue lymphoma. Int J Cancer 110: 695-700.
38. El-Omar EM, Rabkin CS, Gammon MD, Vaughan TL, Risch HA, et al. (2003) Increased risk of noncardia gastric cancer associated with proinflammatory cytokine gene polymorphisms. Gastroenterology 124: 1193-1201.
39. Hwang IR, Kodama T, Kikuchi S, Sakai K, Peterson LE, et al. (2002) Effect of interleukin 1 polymorphisms on gastric mucosal interleukin 1beta production in Helicobacter pylori infection. Gastroenterology 123: 1793-1803.
40. Wang Y, Kato N, Hoshida Y, Yoshida H, Taniguchi H, et al. (2003) Interleukin-1beta gene polymorphisms associated with hepatocellular carcinoma in hepatitis C virus infection. Hepatology 37: 65-71.
41. Howell WM, Turner SJ, Theaker JM, Bateman AC, (2003) Cytokine gene single nucleotide polymorphisms and susceptibility to and prognosis in cutaneous malignant melanoma. Eur J Immunogenet 30: 409-414.
42. Zeng ZR, Hu PJ, Hu S, Pang RP, Chen MH, et al. (2003) Association of interleukin 1B gene polymorphism and gastric cancers in high and low prevalence regions in China. Gut 52: 1684-1689.
43. Tanaka Y, Furuta T, Suzuki S, Orito E, Yeo AE, et al. (2003) Impact of interleukin-1beta genetic polymorphisms on the development of hepatitis C virus-related hepatocellular carcinoma in Japan. J Infect Dis 187: 1822-1825.
44. Zhang Z, Liu W, Jia X, Gao Y, Hemminki K, et al. (2004) Use of pyrosequencing to detect clinically relevant polymorphisms of genes in basal cell carcinoma. Clin Chim Acta 342: 137-143.
45. Yang J, Hu Z, Xu Y, Shen J, Niu J, et al. (2004) Interleukin-1B gene promoter variants are associated with an increased risk of gastric cancer in a Chinese population. Cancer Lett 215: 191-198.
46. Chen A, Li CN, Hsu PI, Lai KH, Tseng HH, et al. (2004) Risks of interleukin-1 genetic polymorphisms and Helicobacter pylori infection in the development of gastric cancer. Aliment Pharmacol Ther 20: 203-211.
47. Zienolddiny S, Ryberg D, Maggini V, Skaug V, Canzian F, et al. (2004) Polymorphisms of the interleukin-1 beta gene are associated with increased risk of non-small cell lung cancer. Int J Cancer 109: 353-356.
48. Lee KA, Ki CS, Kim HJ, Sohn KM, Kim JW, et al. (2004) Novel interleukin 1beta polymorphism increased the risk of gastric cancer in a Korean population. J Gastroenterol 39: 429-433.
49. Grimm C, Berger I, Tomovski C, Zeillinger R, Concin N, et al. (2004) A polymorphism of the interleukin-1 receptor antagonist plays a prominent role within the interleukin-1 gene cluster in vulvar carcinogenesis. Gynecol Oncol 92: 936-940.
50. Hartland S, Newton JL, Griffin SM, Donaldson PT, (2004) A functional polymorphism in the interleukin-1 receptor-1 gene is associated with increased risk of Helicobacter pylori infection but not with gastric cancer. Dig Dis Sci 49: 1545-1550.
51. Glas J, Torok HP, Schneider A, Brunnler G, Kopp R, et al. (2004) Allele 2 of the interleukin-1 receptor antagonist gene is associated with early gastric cancer. J Clin Oncol 22: 4746-4752.
52. Tsai FJ, Chang CH, Chen CC, Hsia TC, Chen HY, et al. (2005) Interleukin-4 gene intron-3 polymorphism is associated with transitional cell carcinoma of the urinary bladder. BJU Int 95: 432-435.
53. Sakuma K, Uozaki H, Chong JM, Hironaka M, Sudo M, et al. (2005) Cancer risk to the gastric corpus in Japanese, its correlation with interleukin-1beta gene polymorphism (+3953*T) and Epstein-Barr virus infection. Int J Cancer 115: 93-97.
54. Alpizar-Alpizar W, Perez-Perez GI, Une C, Cuenca P, Sierra R, (2005) Association of interleukin-1B and interleukin-1RN polymorphisms with gastric cancer in a high-risk population of Costa Rica. Clin Exp Med 5: 169-176.
55. Perri F, Piepoli A, Bonvicini C, Gentile A, Quitadamo M, et al. (2005) Cytokine gene polymorphisms in gastric cancer patients from two Italian areas at high and low cancer prevalence. Cytokine 30: 293-302.
56. Zhang WH, Wang XL, Zhou J, An LZ, Xie XD, (2005) Association of interleukin-1B (IL-1B) gene polymorphisms with risk of gastric cancer in Chinese population. Cytokine 30: 378-381.
57. Chang YW, Jang JY, Kim NH, Lee JW, Lee HJ, et al. (2005) Interleukin-1B (IL-1B) polymorphisms and gastric mucosal levels of IL-1beta cytokine in Korean patients with gastric cancer. Int J Cancer 114: 465-471.
58. Lu W, Pan K, Zhang L, Lin D, Miao X, et al. (2005) Genetic polymorphisms of interleukin (IL)-1B, IL-1RN, IL-8, IL-10 and tumor necrosis factor {alpha} and risk of gastric cancer in a Chinese population. Carcinogenesis 26: 631-636.
59. Ruzzo A, Graziano F, Pizzagalli F, Santini D, Battistelli V, et al. (2005) Interleukin 1B gene (IL-1B) and interleukin 1 receptor antagonist gene (IL-1RN) polymorphisms in Helicobacter pylori-negative gastric cancer of intestinal and diffuse histotype. Ann Oncol 16: 887-892.
60. Tsai MH, Chen WC, Tsai CH, Hang LW, Tsai FJ, (2005) Interleukin-4 gene, but not the interleukin-1 beta gene polymorphism, is associated with oral cancer. J Clin Lab Anal 19: 93-98.
61. Chen CC, Yang SY, Liu CJ, Lin CL, Liaw YF, et al. (2005) Association of cytokine and DNA repair gene polymorphisms with hepatitis B-related hepatocellular carcinoma. Int J Epidemiol 34: 1310-1318.
62. Taguchi A, Ohmiya N, Shirai K, Mabuchi N, Itoh A, et al. (2005) Interleukin-8 promoter polymorphism increases the risk of atrophic gastritis and gastric cancer in Japan. Cancer Epidemiol Biomarkers Prev 14: 2487-2493.
63. Hefler LA, Grimm C, Lantzsch T, Lampe D, Leodolter S, et al. (2005) Interleukin-1 and interleukin-6 gene polymorphisms and the risk of breast cancer in caucasian women. Clin Cancer Res 11: 5718-5721.
64. Asada M, Yasuda H, Ebihara S, Tomita N, Suzuki S, et al. (2006) Interleukin-1beta gene polymorphisms associated with risk of lung cancer in Japanese. Lung Cancer 54: 261-263.
65. Balasubramanian SP, Azmy IA, Higham SE, Wilson AG, Cross SS, et al. (2006) Interleukin gene polymorphisms and breast cancer: a case control study and systematic literature review. BMC Cancer 6: 188.
66. Kim N, Cho SI, Yim JY, Kim JM, Lee DH, et al. (2006) The effects of genetic polymorphisms of IL-1 and TNF-A on Helicobacter pylori-induced gastroduodenal diseases in Korea. Helicobacter 11: 105-112.
67. Kamangar F, Abnet CC, Hutchinson AA, Newschaffer CJ, Helzlsouer K, et al. (2006) Polymorphisms in inflammation-related genes and risk of gastric cancer (Finland). Cancer Causes Control 17: 117-125.
68. Starzynska T, Ferenc K, Wex T, Kahne T, Lubinski J, et al. (2006) The association between the interleukin-1 polymorphisms and gastric cancer risk depends on the family history of gastric carcinoma in the study population. Am J Gastroenterol 101: 248-254.
69. Rothman N, Skibola CF, Wang SS, Morgan G, Lan Q, et al. (2006) Genetic variation in TNF and IL10 and risk of non-Hodgkin lymphoma: a report from the InterLymph Consortium. Lancet Oncol 7: 27-38.
70. Hirankarn N, Kimkong I, Kummee P, Tangkijvanich P, Poovorawan Y, (2006) Interleukin-1beta gene polymorphism associated with hepatocellular carcinoma in hepatitis B virus infection. World J Gastroenterol 12: 776-779.
71. Ikehara SK, Ikehara Y, Matsuo K, Hirose K, Niwa T, et al. (2006) A polymorphism of C-to-T substitution at-31 IL1B is associated with the risk of advanced gastric adenocarcinoma in a Japanese population. J Hum Genet 51: 927-933.
72. Yamada S, Matsuhisa T, Makonkawkeyoon L, Chaidatch S, Kato S, et al. (2006) Helicobacter pylori infection in combination with the serum pepsinogen I/II ratio and interleukin-1beta-511 polymorphisms are independent risk factors for gastric cancer in Thais. J Gastroenterol 41: 1169-1177.
73. Liu J, Zhai X, Jin G, Hu Z, Wang S, et al. (2006) Functional variants in the promoter of interleukin-1beta are associated with an increased risk of breast cancer: a case-control analysis in a Chinese population. Int J Cancer 118: 2554-2558.
74. Michaud DS, Daugherty SE, Berndt SI, Platz EA, Yeager M, et al. (2006) Genetic polymorphisms of interleukin-1B (IL-1B), IL-6, IL-8, and IL-10 and risk of prostate cancer. Cancer Res 66: 4525-4530.
75. Sugimoto M, Furuta T, Shirai N, Nakamura A, Xiao F, et al. (2007) Different effects of polymorphisms of tumor necrosis factor-alpha and interleukin-1 beta on development of peptic ulcer and gastric cancer. J Gastroenterol Hepatol 22: 51-59.
76. Kang S, Kim JW, Park NH, Song YS, Park SY, et al. (2007) Interleukin-1 beta-511 polymorphism and risk of cervical cancer. J Korean Med Sci 22: 110-113.
77. Sun H, Wang Y, Ma X, Pei F, Sun H, et al. (2007) A method of oligochip for single nucleotide polymorphism genotyping in the promoter region of the interleukin-1 beta gene and its clinical application. Oligonucleotides 17: 336-344.
78. Seno H, Satoh K, Tsuji S, Shiratsuchi T, Harada Y, et al. (2007) Novel interleukin-4 and interleukin-1 receptor antagonist gene variations associated with non-cardia gastric cancer in Japan: comprehensive analysis of 207 polymorphisms of 11 cytokine genes. J Gastroenterol Hepatol 22: 729-737.
79. Zumkeller N, Brenner H, Chang-Claude J, Hoffmeister M, Nieters A, et al. (2007) Helicobacter pylori infection, interleukin-1 gene polymorphisms and the risk of colorectal cancer: evidence from a case-control study in Germany. Eur J Cancer 43: 1283-1289.
80. Li C, Xia HH, Xie W, Hu Z, Ye M, et al. (2007) Association between interleukin-1 gene polymorphisms and Helicobacter pylori infection in gastric carcinogenesis in a Chinese population. J Gastroenterol Hepatol 22: 234-239.
81. Lee KM, Shen M, Chapman RS, Yeager M, Welch R, et al. (2007) Polymorphisms in immunoregulatory genes, smoky coal exposure and lung cancer risk in Xuan Wei, China. Carcinogenesis 28: 1437-1441.
82. Abazis-Stamboulieh D, Oikonomou P, Papadoulis N, Panayiotidis P, Vrakidou E, et al. (2007) Association of interleukin-1A, interleukin-1B and interleukin-1 receptor antagonist gene polymorphisms with multiple myeloma. Leuk Lymphoma 48: 2196-2203.
83. Ennas MG, Moore PS, Zucca M, Angelucci E, Cabras MG, et al. (2008) Interleukin-1B (IL1B) and interleukin-6 (IL6) gene polymorphisms are associated with risk of chronic lymphocytic leukaemia. Hematol Oncol 26: 98-103.
84. Hoeft B, Becker N, Deeg E, Beckmann L, Nieters A, (2008) Joint effect between regular use of non-steroidal anti-inflammatory drugs, variants in inflammatory genes and risk of lymphoma. Cancer Causes Control 19: 163-173.
85. Upadhyay R, Jain M, Kumar S, Ghoshal UC, Mittal B, (2008) Potential influence of interleukin-1 haplotype IL-1 beta-511*T-IL-1RN*1 in conferring low risk to middle third location of esophageal cancer: a case-control study. Hum Immunol 69: 179-186.
86. Zhu Y, Xu Y, Wei Y, Liang W, Liao M, et al. (2008) Association of IL-1B gene polymorphisms with nasopharyngeal carcinoma in a Chinese population. Clin Oncol (R Coll Radiol) 20: 207-211.
87. Vishnoi M, Pandey SN, Choudhuri G, Mittal B, (2008) IL-1 gene polymorphisms and genetic susceptibility of gallbladder cancer in a north Indian population. Cancer Genet Cytogenet 186: 63-68.
88. Singh H, Sachan R, Goel H, Mittal B, (2008) Genetic variants of interleukin-1RN and interleukin-1beta genes and risk of cervical cancer. Bjog 115: 633-638.
89. Shin WG, Jang JS, Kim HS, Kim SJ, Kim KH, et al. (2008) Polymorphisms of interleukin-1 and interleukin-2 genes in patients with gastric cancer in Korea. J Gastroenterol Hepatol 23: 1567-1573.
90. Hamacher R, Diersch S, Scheibel M, Eckel F, Mayr M, et al. (2009) Interleukin 1 beta gene promoter SNPs are associated with risk of pancreatic cancer. Cytokine 46: 182-186.
91. Ahirwar DK, Agrahari A, Mandhani A, Mittal RD, (2009) Cytokine gene polymorphisms are associated with risk of urinary bladder cancer and recurrence after BCG immunotherapy. Biomarkers 14: 213-218.
92. Kumar S, Kumar A, Dixit VK, (2009) Evidences showing association of interleukin-1B polymorphisms with increased risk of gastric cancer in an Indian population. Biochem Biophys Res Commun 387: 456-460.
93. Gehmert S, Velapatino B, Herrera P, Balqui J, Santivanez L, et al. (2009) Interleukin-1 beta single-nucleotide polymorphism's C allele is associated with elevated risk of gastric cancer in Helicobacter pylori-infected Peruvians. Am J Trop Med Hyg 81: 804-810.
94. Melo Barbosa HP, Martins LC, Dos Santos SE, Demachki S, Assumpcao MB, et al. (2009) Interleukin-1 and TNF-alpha polymorphisms and Helicobacter pylori in a Brazilian Amazon population. World J Gastroenterol 15: 1465-1471.
95. Whiteman DC, Parmar P, Fahey P, Moore SP, Stark M, et al. (2010) Association of Helicobacter pylori infection with reduced risk for esophageal cancer is independent of environmental and genetic modifiers. Gastroenterology 139: 73-83; quiz e11-72.
96. Wex T, Leodolter A, Bornschein J, Kuester D, Kahne T, et al. (2010) Interleukin 1 beta (IL1B) gene polymorphisms are not associated with gastric carcinogenesis in Germany. Anticancer Res 30: 505-511.
97. Yu J, Zeng Z, Wang S, Tian L, Wu J, et al. (2010) IL-1B-511 polymorphism is associated with increased risk of certain subtypes of gastric cancer in Chinese: a case-control study. Am J Gastroenterol 105: 557-564.
98. Yoo EJ, Park SY, Cho NY, Kim N, Lee HS, et al. (2010) Influence of IL1B polymorphism on CpG island hypermethylation in Helicobacter pylori-infected gastric cancer. Virchows Arch 456: 647-652.
99. Qian N, Chen X, Han S, Qiang F, Jin G, et al. (2010) Circulating IL-1beta levels, polymorphisms of IL-1B, and risk of cervical cancer in Chinese women. J Cancer Res Clin Oncol 136: 709-716.
100. Wu KS, Zhou X, Zheng F, Xu XQ, Lin YH, et al. (2010) Influence of interleukin-1 beta genetic polymorphism, smoking and alcohol drinking on the risk of non-small cell lung cancer. Clin Chim Acta 411: 1441-1446.
101. Al-Tahhan MA, Etewa RL, El Behery MM, (2011) Association between circulating interleukin-1 beta (IL-1beta) levels and IL-1beta C-511T polymorphism with cervical cancer risk in Egyptian women. Mol Cell Biochem 353: 159-165.
102. Lim WY, Chen Y, Ali SM, Chuah KL, Eng P, et al. (2011) Polymorphisms in inflammatory pathway genes, host factors and lung cancer risk in Chinese female never-smokers. Carcinogenesis 32: 522-529.
103. Rizzato C, Canzian F, Rudnai P, Gurzau E, Stein A, et al. (2011) Interaction between functional polymorphic variants in cytokine genes, established risk factors and susceptibility to basal cell carcinoma of skin. Carcinogenesis 32: 1849-1854.
104. He BS, Pan YQ, Xu YF, Zhu C, Qu LL, et al. (2011) Polymorphisms in interleukin-1B (IL-1B) and interleukin 1 receptor antagonist (IL-1RN) genes associate with gastric cancer risk in the Chinese population. Dig Dis Sci 56: 2017-2023.
105. Cigrovski Berkovic M, Catela Ivkovic T, Marout J, Zjacic-Rotkvic V, Kapitanovic S, (2012) Interleukin 1beta gene single-nucleotide polymorphisms and susceptibility to pancreatic neuroendocrine tumors. DNA Cell Biol 31: 531-536.
106. Santos JC, Ladeira MS, Pedrazzoli J Jr, Ribeiro ML, (2012) Relationship of IL-1 and TNF-alpha polymorphisms with Helicobacter pylori in gastric diseases in a Brazilian population. Braz J Med Biol Res 45: 811-817.
107. Zheng C, Huang DR, Bergenbrant S, Sundblad A, Osterborg A, et al. (2000) Interleukin 6, tumour necrosis factor alpha, interleukin 1beta and interleukin 1 receptor antagonist promoter or coding gene polymorphisms in multiple myeloma. Br J Haematol 109: 39-45.
108. Snoussi K, Strosberg AD, Bouaouina N, Ben Ahmed S, Chouchane L, (2005) Genetic variation in pro-inflammatory cytokines (interleukin-1beta, interleukin-1alpha and interleukin-6) associated with the aggressive forms, survival, and relapse prediction of breast carcinoma. Eur Cytokine Netw 16: 253-260.
109. Palli D, Saieva C, Luzzi I, Masala G, Topa S, et al. (2005) Interleukin-1 gene polymorphisms and gastric cancer risk in a high-risk Italian population. Am J Gastroenterol 100: 1941-1948.
110. Al-Moundhri MS, Al-Nabhani M, Al-Bahrani B, Burney IA, Al-Madhani A, et al. (2006) Interleukin-1beta gene (IL-1B) and interleukin 1 receptor antagonist gene (IL-1RN) polymorphisms and gastric cancer risk in an Omani Arab population. Gastric Cancer 9: 284-290.
111. Sicinschi LA, Lopez-Carrillo L, Camargo MC, Correa P, Sierra RA, et al. (2006) Gastric cancer risk in a Mexican population: role of Helicobacter pylori CagA positive infection and polymorphisms in interleukin-1 and-10 genes. Int J Cancer 118: 649-657.
112. Wang W, Ni K, Zhou G, (2007) Association of IL1B polymorphisms with gastric cancer in a Chinese population. Clin Biochem 40: 218-225.
113. Crusius JB, Canzian F, Capella G, Pena AS, Pera G, et al. (2008) Cytokine gene polymorphisms and the risk of adenocarcinoma of the stomach in the European prospective investigation into cancer and nutrition (EPIC-EURGAST). Ann Oncol 19: 1894-1902.
114. Ter-Minassian M, Zhai R, Asomaning K, Su L, Zhou W, et al. (2008) Apoptosis gene polymorphisms, age, smoking and the risk of non-small cell lung cancer. Carcinogenesis 29: 2147-2152.
115. Landvik NE, Hart K, Skaug V, Stangeland LB, Haugen A, et al. (2009) A specific interleukin-1B haplotype correlates with high levels of IL1B mRNA in the lung and increased risk of non-small cell lung cancer. Carcinogenesis 30: 1186-1192.
116. Kiyohara C, Horiuchi T, Takayama K, Nakanishi Y, (2010) IL1B rs1143634 polymorphism, cigarette smoking, alcohol use, and lung cancer risk in a Japanese population. J Thorac Oncol 5: 299-304.
117. Moher D, Liberati A, Tetzlaff J, Altman DG, (2009) Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. PLoS Med 6: e1000097.
118. Lewis AM, Varghese S, Xu H, Alexander HR, (2006) Interleukin-1 and cancer progression: the emerging role of interleukin-1 receptor antagonist as a novel therapeutic agent in cancer treatment. J Transl Med 4: 48.
119. Speirs V, Kerin MJ, Newton CJ, Walton DS, Green AR, et al. (1999) Evidence for transcriptional activation of ERalpha by IL-1beta in breast cancer cells. Int J Oncol 15: 1251-1254.
120. Muerkoster S, Wegehenkel K, Arlt A, Witt M, Sipos B, et al. (2004) Tumor stroma interactions induce chemoresistance in pancreatic ductal carcinoma cells involving increased secretion and paracrine effects of nitric oxide and interleukin-1beta. Cancer Res 64: 1331-1337.
121. Stefani AL, Basso D, Panozzo MP, Greco E, Mazza S, et al. (1999) Cytokines modulate MIA PaCa 2 and CAPAN-1 adhesion to extracellular matrix proteins. Pancreas 19: 362-369.
122. ten Kate M, Hofland LJ, van Koetsveld PM, Jeekel J, van Eijck CH, (2006) Pro-inflammatory cytokines affect pancreatic carcinoma cell. Endothelial cell interactions. Jop 7: 454-464.
123. Angst E, Reber HA, Hines OJ, Eibl G, (2008) Mononuclear cell-derived interleukin-1 beta confers chemoresistance in pancreatic cancer cells by upregulation of cyclooxygenase-2. Surgery 144: 57-65.
124. Tian Z, Shen X, Feng H, Gao B, (2000) IL-1 beta attenuates IFN-alpha beta-induced antiviral activity and STAT1 activation in the liver: involvement of proteasome-dependent pathway. J Immunol 165: 3959-3965.
125. Hulkkonen J, Laippala P, Hurme M, (2000) A rare allele combination of the interleukin-1 gene complex is associated with high interleukin-1 beta plasma levels in healthy individuals. Eur Cytokine Netw 11: 251-255.
126. Xue H, Lin B, Ni P, Xu H, Huang G, (2010) Interleukin-1B and interleukin-1 RN polymorphisms and gastric carcinoma risk: a meta-analysis. J Gastroenterol Hepatol 25: 1604-1617.